Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports
Go Back
View Our Subscription Options

Search

Descriptive Alt Text

Filters

Showing results 1,073–1,080 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Brainstorm Cell Therapeutics Inc. NurOwn Progressive Multiple Sclerosis (MS) Phase 2 Trial Completed Intrathecal Neurology
Brainstorm Cell Therapeutics Inc. NurOwn Amytrophic lateral sclerosis (ALS) Phase 3 IND Clearance Intrathecal Neurology
Brainstorm Cell Therapeutics Inc. NurOwn Amytrophic lateral sclerosis (ALS) Phase 3 IND Clearance Intrathecal Neurology
BriaCell Therapeutics Corp. SV-BR-1-GM Metastatic breast cancer Phase 2 Ongoing Intradermal Oncology
BriaCell Therapeutics Corp. Bria-IMT + check point inhibitor (CPI) - (investigator-initiated trial) Metastatic breast cancer Phase 2 Data Released Intravenous Oncology
BriaCell Therapeutics Corp. Bria-IMT - (BRIA-ABC) Advanced breast cancer Phase 3 Data Released Intravenous Oncology
BridgeBio Pharma Inc. Encaleret - (CALIBRATE) Autosomal Dominant Hypocalcemia Type 1 (ADH1) NDA Filing Ongoing oral Genetic Disorder
BridgeBio Pharma Inc. BBP-418 - (FORTIFY) Limb Girdle Muscular Dystrophy Type 2i (LGMD2i) NDA Filing Data Released Oral Genetic Disorder
1…133134135136137…553
Your trusted source for drug reimbursement data and buy-and-bill insights.
Platform
Resources
Tools
Search Drugs
Newsletter
Reimbursement updates, drug pricing news.
© 2026 BuyandBill.com, All Rights Reserved.
HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, America's Health Insurance Plans, and Blue Cross and Blue Shield Association). CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.